Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOvoca Bio Regulatory News (OVB)

  • There is currently no data for OVB

Further re Norplat Ltd

12 May 2005 13:20

Ovoca Resources PLC12 May 2005 NEWS RELEASE May 12, 2005 Ovoca Resource plc ('Ovoca' or the 'Company') Further Information on Norplat Limited ('Norplat') Following the acquisition of a 78 percent interest in Norplat Limited thedirectors of Ovoca Resources plc (OVG.I Dublin and OVG.L London) wish toprovide further information on the exploration assets the Company has acquired. Norplat Limited is a private exploration company created six years ago by formerOxus Gold Plc Managing Directors for the purposes of exploiting the mineralpotential of the Russian Federation, in particular focussing on platinum andgold deposits in northwest Russia. The directors of Norplat, supported by ateam of local and western geological professionals, have between them over 95years of experience in developing mineral properties in the Former Soviet Union. Norplat owns a 95 percent equity interest in its Russian subsidiary "Black FoxResources AOA " which currently holds the 152 square kilometre Kolmozero-Voronyaexploration license in the Kola Peninsula of northwest Russia near the Finnishborder. The license encompasses a number of mineral prospects which includeplatinum, gold, copper, molybdenum, nickel and rare earth minerals. Two exploration prospects, Oleninskoye and Nyalm, have already been drilled andtrenched with combined resources of 900,000 ounces of gold so far outlined inthe P1 category based on the Russian resource classification methodology. The2005 trenching and a 7,000 metre diamond drilling programme has alreadycommenced on both prospects. This follows on from the results of last year'sdrilling programme and assay results are expected in the coming weeks. At Oleninskoye, the more advanced prospect, the 2004 and previous drillingprogrammes have indicated that gold mineralisation occurs in quartz lenses ofthickness ranging from 2 to 5 metres with an average strike length of 85 metresand an overall strike length of 5 kilometers for all six mineralised zones.Drill intersections indicated that the gold mineralisation extends to depths inexcess of 100 metres and is open both along strike and in depth. A recentresource estimate calculated by Norplat based on drilling on Vein 3 has outlined1,020,000 tonnes at an average grade of 13.9 grammes per tonne and a goldequivalent of 455,000 ounces. In addition to this gold mineralisation, recentdrilling has intersected spatially related platinum mineralisation within themetabasalt and metadiabase host rocks of the gold bearing quartz veins andstockworks with platinum grades of up to 3.2 grammes per tonne over thicknessesof over 10 metres. It is believed that these host rocks are extensive throughoutthe license and assays from reject samples from previous gold exploration,before Norplat's ownership of the licence, indicate the presence of platinum inother gold prospects where assays for platinum were not run. The acquisition of a 78 percent shareholding in Norplat, with a call option toacquire the remaining Norplat issued shares and warrants, has not onlydramatically increased the resource base of Ovoca but has brought onboard adynamic experienced technical management team to advance not only the Kolaprojects but also the licenses in Sweden and Ireland. Further information will be provided on the results of the 2005 drillingprogramme and prospects for all of the Company's exploration prospects in duecourse. Contacts Barrie Oakes +44 (0)7951139266 Roger Turner +44 (0)773092813 John O'Connor +353 (0)1 491 2944 Richard O'Shea +353 (0)87 2560397 John Frain (Davy Corporate Finance) +353 (0)1 679 6363 This announcement has been issued through the Companies Announcement Service of the Irish Stock Exchange. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
5th Feb 20267:00 amRNSChange of Name
28th Jan 20268:00 amRNSReadmission - Ovoca Bio PLC
28th Jan 20267:00 amRNSFirst Day of Dealings on AIM
27th Jan 20262:32 pmRNSResult of Meeting
31st Dec 20258:00 amRNSSchedule One - Ovoca Bio Plc
31st Dec 20258:00 amRNSSchedule One - Ovoca Bio Plc
31st Dec 20257:00 amRNSNotice of AGM
31st Dec 20257:00 amRNSPublication of Admission Document
31st Dec 20257:00 amRNSPublication of Admission Document
31st Dec 20257:00 amRNSNotice of AGM
13th Nov 20257:00 amRNSChange of Broker
30th Sep 20251:09 pmRNSReplacement Half Year Report
30th Sep 20257:00 amRNSHalf-year Report
26th Jun 20257:00 amRNSPublication of 2024 Annual Report
5th Jun 20257:00 amRNSDelisting from Euronext Growth Exchange
7th May 20257:30 amRNSSuspension - Ovoca Bio plc
7th May 20257:00 amRNSProposed Acquisition, Disposal & Reverse Takeover
3rd Mar 20252:00 pmRNSManagement Changes
18th Dec 20246:00 pmRNSResult of AGM
18th Nov 20247:00 amRNSNotice of AGM
11th Oct 20245:30 pmRNSHolding(s) in Company
9th Oct 20245:45 pmRNSSale of Treasury Shares
25th Sep 20247:00 amRNSHalf-year Report
2nd Sep 20242:30 pmRNSConsultancy Agreement
15th Jul 20247:00 amRNSDirector/PDMR Shareholding
15th Jul 20247:00 amRNSDirectorate Change
28th Jun 20247:00 amRNSAnnual Financial Report
23rd Jan 20247:00 amRNSHolding(s) in Company
1st Dec 202312:00 pmRNSResult of AGM
7th Nov 20239:15 amRNSNotice of AGM
28th Sep 20237:00 amRNSInterim Results
31st Aug 20237:00 amRNSSummary Results of Phase II Study for Orenetide
30th Jun 20237:00 amRNSAnnual Financial Report
12th Jun 20237:00 amRNSUpdate on Completion Timelines for Phase II Study
16th Mar 20234:35 pmRNSPrice Monitoring Extension
16th Mar 20232:05 pmRNSSecond Price Monitoring Extn
16th Mar 20232:00 pmRNSPrice Monitoring Extension
16th Mar 20239:05 amRNSSecond Price Monitoring Extn
16th Mar 20239:00 amRNSPrice Monitoring Extension
8th Mar 20237:00 amRNSDisposal of Russian Assets
14th Feb 20234:41 pmRNSSecond Price Monitoring Extn
14th Feb 20234:35 pmRNSPrice Monitoring Extension
14th Feb 20232:05 pmRNSSecond Price Monitoring Extn
14th Feb 20232:00 pmRNSPrice Monitoring Extension
13th Feb 20239:00 amRNSPrice Monitoring Extension
13th Jan 202311:05 amRNSSecond Price Monitoring Extn
13th Jan 202311:00 amRNSPrice Monitoring Extension
28th Oct 20227:00 amRNSResult of AGM
6th Oct 20222:30 pmRNSNotice of AGM
30th Sep 20227:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.